AKBLF
Price
$28.20
Change
+$0.55 (+1.99%)
Updated
Jul 2 closing price
Capitalization
6.51B
VBIZF
Price
$0.20
Change
-$0.04 (-16.67%)
Updated
Jul 1 closing price
Capitalization
393.22M
Interact to see
Advertisement

AKBLF vs VBIZF

Header iconAKBLF vs VBIZF Comparison
Open Charts AKBLF vs VBIZFBanner chart's image
Alk Abello AS
Price$28.20
Change+$0.55 (+1.99%)
Volume$65
Capitalization6.51B
Viva Biotech Holdings
Price$0.20
Change-$0.04 (-16.67%)
Volume$3K
Capitalization393.22M
AKBLF vs VBIZF Comparison Chart in %
Loading...
AKBLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKBLF vs. VBIZF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKBLF is a Buy and VBIZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AKBLF: $28.20 vs. VBIZF: $0.20)
Brand notoriety: AKBLF and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKBLF: 934% vs. VBIZF: 112%
Market capitalization -- AKBLF: $6.51B vs. VBIZF: $393.22M
AKBLF [@Biotechnology] is valued at $6.51B. VBIZF’s [@Biotechnology] market capitalization is $393.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKBLF’s FA Score shows that 0 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • AKBLF’s FA Score: 0 green, 5 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, AKBLF is a better buy in the long-term than VBIZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKBLF’s TA Score shows that 3 TA indicator(s) are bullish while VBIZF’s TA Score has 3 bullish TA indicator(s).

  • AKBLF’s TA Score: 3 bullish, 2 bearish.
  • VBIZF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AKBLF is a better buy in the short-term than VBIZF.

Price Growth

AKBLF (@Biotechnology) experienced а +1.99% price change this week, while VBIZF (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKBLF($6.51B) has a higher market cap than VBIZF($393M). AKBLF has higher P/E ratio than VBIZF: AKBLF (42.64) vs VBIZF (23.65). VBIZF YTD gains are higher at: 179.267 vs. AKBLF (26.174).
AKBLFVBIZFAKBLF / VBIZF
Capitalization6.51B393M1,657%
EBITDA1.55BN/A-
Gain YTD26.174179.26715%
P/E Ratio42.6423.65180%
Revenue5.71BN/A-
Total Cash517MN/A-
Total Debt800MN/A-
FUNDAMENTALS RATINGS
AKBLF: Fundamental Ratings
AKBLF
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKBLFVBIZF
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
24%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
20%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
34%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
34%
Bearish Trend 1 day ago
58%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
37%
Bullish Trend 1 day ago
19%
View a ticker or compare two or three
Interact to see
Advertisement
AKBLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DMSZX9.99N/A
N/A
Destinations Multi Strategy Alts Z
PQCCX9.71N/A
N/A
PGIM Quant Solutions Mid-Cap Index R6
VYSAX14.76N/A
N/A
Voya Small Company I
OEGCX19.73N/A
N/A
Invesco Discovery Mid Cap Growth C
IBARX24.94N/A
N/A
Macquarie Balanced Fund Class R6

AKBLF and

Correlation & Price change

A.I.dvisor tells us that AKBLF and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKBLF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKBLF
1D Price
Change %
AKBLF100%
N/A
MNPR - AKBLF
29%
Poorly correlated
+3.10%
MSCLF - AKBLF
27%
Poorly correlated
N/A
IOVA - AKBLF
26%
Poorly correlated
N/A
SMMT - AKBLF
25%
Poorly correlated
+8.53%
VBIZF - AKBLF
24%
Poorly correlated
N/A
More

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with SMMT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
SMMT - VBIZF
42%
Loosely correlated
+8.53%
BCLI - VBIZF
35%
Loosely correlated
-0.85%
AKBLF - VBIZF
24%
Poorly correlated
N/A
SPHRY - VBIZF
11%
Poorly correlated
+8.88%
WXXWY - VBIZF
5%
Poorly correlated
+0.08%
More